May 21, 2018 9:09 PM ET

Life Sciences Tools and Services

Company Overview of Personalis, Inc.

Company Overview

Personalis, Inc., a precision medicine company, offers next–generation sequencing-based clinical diagnostic and research services for cancer and inherited genetic diseases. The company provides researchers and clinicians DNA sequencing and interpretation of human exomes and genomes. It also offers ACE Platform, a sequencing and analysis solution to address research and diagnostic questions; ACE ImmunoID, a solution to obtain genomic and transcriptomic data for neoantigen identification; Athena Diagnostics, a diagnostic test for neurological disease cases; and DNA Analysis pipeline for cancer performs alignment and variant calling for germline and somatic variants. In addition, the company pr...

1330 O’Brien Drive

Menlo Park, CA 94025

United States

Founded in 2011

Phone:

650-752-1300

Fax:

650-752-1301

Key Executives for Personalis, Inc.

Co-Founder, Chief Executive Officer and Director
Co-Founder and Member of Clinical & Scientific Advisory Board
Co-Founder and Member of Clinical & Scientific Advisory Board
Co-Founder and Member of Clinical & Scientific Advisory Board
Co-Founder and Member of Clinical & Scientific Advisory Board
Compensation as of Fiscal Year 2017.

Personalis, Inc. Key Developments

Personalis Presents at 4th Annual ICI Boston, Mar-20-2018 12:00 PM

Personalis Presents at 4th Annual ICI Boston, Mar-20-2018 12:00 PM. Venue: Revere Hotel, 200 Stuart St, Boston, Boston, Massachusetts, United States. Speakers: Christelle Johnson, Senior Field Applications Scientist, Cancer Genomics & ImmunoOncology.

Personalis, Inc. Releases the Latest Version of NeoantigenID for Enhanced Neoantigen Identification on the ACE ImmunoID Platform

Personalis, Inc. announced the latest release of NeoantigenID™, a component of the ACE ImmunoID™ Platform. ACE ImmunoID, which uses Personalis’ patented ACE Technology™, combines augmented exome and transcriptome sequencing with analytics to enable broad tumor immunogenomic characterization. This newest release of NeoantigenID not only identifies candidate neoantigens derived from single nucleotide variants (SNVs), but now also includes putative neoantigens derived from insertion and deletion mutations (indels) and gene fusions, for both MHC Class I and Class II. The new analytics integrate DNA and RNA sequencing data to calculate neoantigen load, expression of genes, and expression of variants, while incorporating phasing information to improve the accuracy of neoantigen prediction.

Personalis, Inc. Presents at Precision Medicine World Conference - Silicon Valley, Jan-23-2018 03:30 PM

Personalis, Inc. Presents at Precision Medicine World Conference - Silicon Valley, Jan-23-2018 03:30 PM. Venue: Computer History Museum, 1401 N Shoreline Blvd., Mountain View, California, United States. Speakers: Richard Chen, Chief Scientific Officer.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
June 29, 2017
--
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Personalis, Inc., please visit www.personalis.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.